Glad to see this company is picking up some stars.Repeat pitch from 3/21/07:How can this stock be rated at one star?!This company has seen solid growth in all quarters for almost the entirety of their existence, and there's no reason for it to stop… More
Managements sucks. Sales reps won't hit their numbers. HOWEVER, they have solid products and if they figure out a way to stop or reduce CAD/PAD through their biologics/Merk department. This stock will become a gangbusters. Short short term. Solid… More